Sara Raudenbush 1

Sara Raudenbush


People profiles

Sara Raudenbush

Professional Background

  • 13 years of professional management consulting experience
  • Strategy and Transformation Consultant for: Corporations, Private Equity firms and Consulting Companies
  • Double BBS Operations Management and Marketing. Masters of Science in Strategic Intelligence.
  • Driving Corporate Performance Executive Education Certificate Harvard Business School 2020
  • Six Sigma Green Belt

M&A Skills & Expertise

  • End to end Supply Chain Consulting with Operations Management Subject Matter expertise. 
  • Strategic Design experience includes; Corporate Strategy, Goal cascading, KPI alignment and Organizational Design and Rightsizing for global and national organizations. 
  • Industry experience; Food and beverage, FMCG, personal care, retail (soft and hard lines), insurance, petfood, agriculture, oil and gas. Heavy industry experience includes; Mining, transportation, chemicals, energy, aerospace, and  Industrial Manufacturing.
  • Department experience: Production, Operations, Maintenance, HSE, Logistics, Warehouse, HR, Procurement, Planning & Scheduling, Sales.
  • Implementation experience in the U.S, South Africa, Botswana, Canada, and China

Project Highlights

  • Logistics: Crowley Logistics: protected position as one of the industry leaders in global freight carriage and reversed logistics business unit’s standing $25M loss. 
  • FMCG: (food) Delivered Colony Brands’ optimized manufacturing operations and supply chain org assessment; deployed Lean aligned with ISO 31000, installed MOS, and shaped org design and S&OP strategy.
  • Aerospace & Defense: Eagle-Picher: following acquisition of Vectra Eagle-Picher by Apollo Global Management (PE firm), positioned business for potential sale and laid foundation for separation from Vectra; drove manufacturing optimization and HC reduction of 30%
  • Agriculture: Bayer: Increased capacity in Row Crop division as part of post acquisition of Monsanto aimed at movement of production volume to various plants to boost revenue; 
  • Pharma: Executed stand up for Noramco a controlled substance intermediary manufacturer as a Johnson and Johnson divestiture via SK Capital.

We use cookies to give you the best experience with our website. By continuing to browse this site, you are agreeing to our use of cookies. For more on how we use information collected, please see our Privacy Policy.